Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors

Chiho Kim, Xu Dong Wang, Zhengshuai Liu, Jianwei Hao, Shuai Wang, Peng Li, Zhenzhen Zi, Qing Ding, Seoyeon Jang, Jiwoong Kim, Yikai Luo, Kenneth E. Huffman, Shreoshi Pal Choudhuri, Sofia del Rio, Ling Cai, Han Liang, Benjamin J. Drapkin, John D. Minna, Yonghao Yu

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences